Sonoma Pharmaceuticals (SNOA) Stock Chart & Stock Price History $2.79 +0.11 (+4.10%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Sonoma Pharmaceuticals Stock Price Performance5 Day Performance-7.00%1 Month Performance-5.10%3 Month Performance+769.16%6 Month Performance+1,722.34%Year-To-Date Performance+1,446.56%1 Year Performance+1,526.82% Receive SNOA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. SNOA Stock Chart for Saturday, November, 2, 2024 SNOA Chart by TradingView Sonoma Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$2.68$2.79+4.10%$2.85$2.6921,531 shs$2.67 million10/31/2024$2.90$2.68-7.59%$2.90$2.6856,436 shs$2.57 million10/30/2024$2.90$2.90$2.90$2.7814,458 shs$2.78 million10/29/2024$3.00$2.90-3.33%$3.00$2.9022,868 shs$2.78 million10/28/2024$2.99$3.00+0.33%$3.05$2.9220,039 shs$2.88 million10/25/2024$2.90$2.99+3.10%$3.07$2.8828,898 shs$2.87 million Get the Latest News and Ratings for SNOA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$2.80$2.90+3.57%$2.98$2.7458,423 shs$55.11 million10/23/2024$2.85$2.80-1.75%$2.88$2.7130,471 shs$2.69 million10/22/2024$2.97$2.85-4.04%$2.98$2.60330,275 shs$54.16 million10/21/2024$3.16$2.97-6.01%$3.34$2.9543,134 shs$56.44 million10/18/2024$2.93$3.16+7.85%$3.23$2.9484,647 shs$60.05 million10/17/2024$2.94$2.93-0.34%$2.99$2.8417,563 shs$55.68 million10/16/2024$2.96$2.94-0.68%$3.05$2.8636,391 shs$55.87 million10/15/2024$3.08$2.96-3.90%$3.18$2.9344,774 shs$56.25 million10/14/2024$3.11$3.08-0.81%$3.32$2.92145,568 shs$58.53 million10/11/2024$3.00$3.11+3.50%$3.40$3.01218,958 shs$2.98 million10/10/2024$2.86$3.00+4.90%$3.10$2.83241,042 shs$57.01 million10/09/2024$2.67$2.86+7.12%$2.93$2.6049,075 shs$54.35 million10/08/2024$2.64$2.67+1.14%$2.77$2.5266,153 shs$50.74 million10/07/2024$2.78$2.64-5.04%$2.79$2.5671,474 shs$50.17 million10/04/2024$2.85$2.78-2.46%$2.89$2.7252,844 shs$52.83 million10/03/2024$2.94$2.85-3.06%$2.94$2.8257,535 shs$54.16 million10/02/2024$2.96$2.94-0.68%$3.07$2.9027,356 shs$55.87 million10/01/2024$3.07$2.96-3.58%$3.24$2.8840,788 shs$56.25 million09/30/2024$3.21$3.07-4.36%$3.33$3.07109,733 shs$58.34 million09/27/2024$3.21$3.21$3.38$3.16116,160 shs$61.00 million09/26/2024$3.22$3.21-0.31%$3.35$3.2068,297 shs$61.00 million09/25/2024$3.31$3.22-2.72%$3.30$3.1070,940 shs$3.09 million09/24/2024$3.18$3.31+4.09%$3.45$3.21121,473 shs$62.90 million09/23/2024$3.46$3.18-8.09%$3.47$3.05170,581 shs$60.43 million09/20/2024$3.83$3.46-9.66%$3.77$3.34276,919 shs$65.75 million09/19/2024$4.30$3.83-10.93%$4.48$3.651.27 million shs$72.79 million09/18/2024$5.20$4.30-17.31%$5.13$3.641.77 million shs$81.72 million09/17/2024$4.21$5.20+23.52%$5.93$3.372.38 million shs$98.82 million09/16/2024$3.50$4.21+20.29%$4.44$3.60444,495 shs$4.04 million09/13/2024$3.17$3.50+10.41%$3.76$3.2063,549 shs$3.36 million09/12/2024$3.27$3.17-3.06%$3.63$3.1734,215 shs$60.24 million09/11/2024$3.15$3.27+3.81%$3.67$3.1755,799 shs$3.14 million09/10/2024$3.15$3.15$3.26$3.126,492 shs$3.02 million09/09/2024$3.28$3.15-3.96%$3.40$3.1512,313 shs$3.02 millionNvidia warning urgent (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.09/06/2024$3.16$3.28+3.80%$3.34$3.1029,806 shs$62.33 million09/05/2024$3.20$3.16-1.27%$3.40$3.1467,424 shs$60.05 million09/04/2024$2.81$3.20+13.90%$3.20$2.7384,807 shs$60.83 million09/03/2024$3.30$2.81-14.85%$3.39$2.7076,617 shs$53.40 million09/02/2024$3.30$3.30$3.89$2.95206,600 shs$3.17 million08/30/2024$0.16$3.30+1,970.91%$3.89$2.95206,121 shs$62.71 million08/29/2024$0.16$0.16-2.06%$0.17$0.151.06 million shs$3.03 million08/28/2024$0.22$0.16-24.99%$0.20$0.162.96 million shs$3.09 million08/27/2024$0.23$0.22-7.62%$0.24$0.21765,826 shs$4.12 million08/26/2024$0.24$0.23-2.98%$0.24$0.221.61 million shs$4.46 million08/23/2024$0.23$0.24+7.08%$0.25$0.23673,148 shs$4.60 million08/22/2024$0.22$0.23+1.76%$0.24$0.221.30 million shs$4.30 million08/21/2024$0.24$0.22-9.12%$0.28$0.2018.23 million shs$4.22 million08/20/2024$0.26$0.24-6.04%$0.26$0.24302,198 shs$4.68 million08/19/2024$0.25$0.26+4.04%$0.27$0.26804,663 shs$4.98 million08/16/2024$0.23$0.25+6.43%$0.25$0.23714,423 shs$4.75 million08/15/2024$0.24$0.23-0.89%$0.24$0.23532,556 shs$4.46 million08/14/2024$0.23$0.24+1.54%$0.25$0.23379,199 shs$4.50 million08/13/2024$0.22$0.23+5.04%$0.25$0.22254,385 shs$4.44 million08/12/2024$0.25$0.22-10.37%$0.25$0.20960,886 shs$4.22 million08/09/2024$0.31$0.25-19.99%$0.29$0.211.66 million shs$4.69 million08/08/2024$0.28$0.31+11.61%$0.31$0.28701,809 shs$5.87 million08/07/2024$0.30$0.28-7.80%$0.32$0.271.06 million shs$5.26 million08/06/2024$0.30$0.30-0.56%$0.32$0.30368,717 shs$5.70 million08/05/2024$0.32$0.30-6.01%$0.31$0.281.20 million shs$5.73 million08/02/2024$0.35$0.32-9.27%$0.38$0.32668,763 shs$6.72 million08/01/2024$0.37$0.35-3.07%$0.39$0.35413,103 shs$6.72 million Related Companies Eton Pharmaceuticals Stock Chart Zura Bio Stock Chart Procaps Group Stock Chart Atai Life Sciences Stock Chart Rezolute Stock Chart Fulcrum Therapeutics Stock Chart Bright Minds Biosciences Stock Chart Pyxis Oncology Stock Chart Cabaletta Bio Stock Chart Nkarta Stock Chart Receive SNOA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SNOA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
